No Data
No Data
Express News | A group of Jing-Jin-Ji funds signed contracts with enterprises to empower the industry chain.
Beijing Centergate Technologies (000931.SZ): The registration application for non-busertan tablets pharmaceutical has been accepted.
Beijing Centergate Technologies (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd. (referred to as Duoduo Pharmaceutical), ...
Express News | Beijing centergate technologies: Huasu in beijing successfully obtained the patent rights related to the sustained-release chewable tablets of Paroxetine Hydrochloride.
Beijing centergate technologies (000931.SZ): Subsidiary company Beijing Huasu has obtained an invention patent certificate.
On November 12th, Gelunhui announced that its subsidiary, Beijing Huasu Pharmaceutical Co., Ltd., recently obtained the invention patent certificate issued by the National Intellectual Property Administration, with the invention name being a one-time testing method for a substance related to bisoprolol hydrochlorothiazide tablets.
Express News | Beijing Centergate Technologies: Duoduo Pharmaceutical's Nifubusitant Tablets accepted by the National Medical Products Administration.
Express News | China Unicom's 'Tongzhou' enterprise digital enablement platform innovation achievements released.
No Data
No Data